Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
153,881,229
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
75,135,656
-
Shares change
-
+41,749,451
-
Total reported value, excl. options
-
$176,537,613
-
Value change
-
+$98,192,610
-
Put/Call ratio
-
185%
-
Number of buys
-
69
-
Number of sells
-
24
-
Price
-
$2.35
Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q1 2024
As of 31 Mar 2024 Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) had 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 75,135,656 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., TANG CAPITAL MANAGEMENT LLC, Balyasny Asset Management L.P., RTW INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, BlackRock Inc., and VANGUARD GROUP INC.
This table shows 96 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.